HPV vaccine for cancer and wart prevention

被引：0
|
作者：
Kolber, Michael R. [1 ]
Lindblad, Adrienne J. [2 ]
机构：
[1] Univ Alberta, Dept Family Med, Edmonton, AB, Canada
[2] Alberta Coll Family Phys, Edmonton, AB, Canada
来源：
CANADIAN FAMILY PHYSICIAN | 2015年 / 61卷 / 01期
关键词：
HUMAN-PAPILLOMAVIRUS; INFECTION; EFFICACY;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [41] Can cervical cancer be eradicated by prophylactic HPV vaccination? Challenges to vaccine implementation
    Garland, Suzanne M.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2009, 130 (03) : 311 - 321
  • [42] Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis
    Zou, Zhuoru
    Fairley, Christopher K.
    Ong, Jason J.
    Hocking, Jane
    Canfell, Karen
    Ma, Xiaomeng
    Chow, Eric P. F.
    Xu, Xianglong
    Zhang, Lei
    Zhuang, Guihua
    LANCET GLOBAL HEALTH, 2020, 8 (10): : E1335 - E1344
  • [43] Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
    Kavanagh, K.
    Pollock, K. G. J.
    Potts, A.
    Love, J.
    Cuschieri, K.
    Cubie, H.
    Robertson, C.
    Donaghy, M.
    BRITISH JOURNAL OF CANCER, 2014, 110 (11) : 2804 - 2811
  • [44] HPV vaccines for circumpolar health: summary of plenary session, "Opportunities for Prevention: Global HPV Vaccine" and "Human Papillomavirus Prevention: The Nordic Experience"
    Dunne, Eileen F.
    Koch, Anders
    INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2013, 72 : 101 - 105
  • [45] Clinical Perspectives on the Role of the Human Papillomavirus Vaccine in the Prevention of Cancer
    Julius, Justin M.
    Ramondeta, Lois
    Tipton, Katherine A.
    Lal, Lincy S.
    Schneider, Karen
    Smith, Judith A.
    PHARMACOTHERAPY, 2011, 31 (03): : 280 - 297
  • [46] Brazilian Immigrant Parents’ Awareness of HPV and the HPV Vaccine and Interest in Participating in Future HPV-Related Cancer Prevention Study: an Exploratory Cross-Sectional Study Conducted in the USA
    Ana Cristina Lindsay
    Mary L. Greaney
    Luísa M. Rabello
    YuJin Y. Kim
    Sherrie F. Wallington
    Journal of Racial and Ethnic Health Disparities, 2020, 7 : 829 - 837
  • [47] HPV: Diagnosis, Prevention, and Treatment
    Hathaway, Jon K.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2012, 55 (03) : 671 - 680
  • [48] Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine
    Petry, Karl-Ulrich
    Bollaerts, Kaatje
    Bonanni, Paolo
    Stanley, Margaret
    Drury, Rosybel
    Joura, Elmar
    Kjaer, Susanne K.
    Meijer, Chris J. L. M.
    Riethmuller, Didier
    Soubeyrand, Benoit
    Van Damme, Pierre
    Bosch, Xavier
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (07) : 1800 - 1806
  • [49] The Prospects of HPV Vaccination in Cervical Cancer Prevention: Results of a New Independent Trial
    Xavier Bosch, F.
    de Sanjose, Silvia
    Castellsague, Xavier
    CANCER DISCOVERY, 2011, 1 (05) : 377 - 380
  • [50] Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States-Do we need a broader vaccine policy?
    Osazuwa-Peters, N.
    VACCINE, 2013, 31 (47) : 5500 - 5505
12345